# CEIR Publications 2018

2 publications

## 1. Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

**Authors:** James G Hakim, Jennifer Thompson, Cissy Kityo, Anne Hoppe, Andrew Kambugu, Joep J van Oosterhout, Abbas Lugemwa, Abraham Siika, Raymond Mwebaze, Aggrey Mweemba, George Abongomera, Margaret J Thomason, Philippa Easterbrook, Peter Mugyenyi, A Sarah Walker, Nicholas I Paton, Europe Africa Research Network for Evaluation of Second-line Therapy (EARNEST) Trial Team
**Journal:** Lancet Infectious Diseases
**DOI:** [10.1016/S1473-3099(17)30630-8](https://doi.org/10.1016/S1473-3099(17)30630-8)
**PubMed:** https://pubmed.ncbi.nlm.nih.gov/29108797?dopt=Citation
**CEIR authors:** Eugenia Rinaldi

## 2. Cell cycle arrest and cell death correlate with the extent of ischaemia and reperfusion injury in patients following kidney transplantation - results of an observational pilot study

**Authors:** Felix C F Schmitt, Eduardo Salgado, Janina Friebe, Thomas Schmoch, Florian Uhle, Thomas Fleming, Johanna Zemva, Lars Kihm, Christian Nusshag, Christian Morath, Martin Zeier, Thomas Bruckner, Arianeb Mehrabi, Peter P Nawroth, Markus A Weigand, Stefan Hofer, Thorsten Brenner
**Journal:** Transplant International
**DOI:** [10.1111/tri.13148](https://doi.org/10.1111/tri.13148)
**PubMed:** https://pubmed.ncbi.nlm.nih.gov/29505681?dopt=Citation
**CEIR authors:** Eduardo Salgado
